Skip to main content
. 2022 Oct 28;12:101. doi: 10.1186/s13613-022-01075-9

Table 1.

Overall population characteristics stratified according to etoposide status

Overall (n = 168) No etoposide (n = 33) Etoposide (n = 135) p
Demographics
 Age 49 [38, 59] 49 [36, 59] 49 [38, 60] 0.811
 Female gender 57 (34) 14 (42) 43(32) 0.345
 Etiology of HS  < 0.001
 Malignancy 123 (73.2) 15 (45.5) 108 (80.0)
 Infection 25 (14.9) 13 (39.4) 12 (8.9)
 Auto-immune 6 (3.6) 1 (3.0) 5 (3.7)
 Other 3 (1.8) 0 (0) 3 (2.2)
 Unknown 11 (6.5) 4 (12.1) 7 (5.2)
Comorbidities
 HIV 56 (33.3) 6 (18.2) 50 (37.0) 0.064
 Hypertension 28 (16.7) 11 (33.3) 17 (12.6) 0.009
 Diabetes 14 (8.3) 2 (6.1) 12 (8.9) 0.861
 Chronic kidney disease 9 (5.4) 4 (12.1) 5 (3.7) 0.135
 Immunocompromised 100 (59.5) 17 (51.5) 83 (61.5) 0.397
Features of HLH
 HLH-2004 criteria 5 [4, 6] 4 [4, 5] 5 [5, 6] 0.016
 HScore 247 [217, 273] 225 [195, 269] 249 [225, 278] 0.029
 Hepatomegaly 120 (71.4) 18 (54.5) 102 (75.6) 0.029
 Splenomegaly 103 (62.4) 14 (43.8) 89 (66.9) 0.026
 Bicytopenia 132 (78.6) 21 (63.6) 111 (82.2) 0.036
 Ferritin (µg/L) 10015 [4982, 32471] 6880 [3705, 18316] 10644 [5297, 40449] 0.025
 Fibrinogen (g/L) 3.1 [1.6, 4.9] 3.4 [2.3, 5.1] 2.7 [1.5, 4.8] 0.199
 Triglycerides (mmol/L) 3.2 [2.3, 4.3] 3.3 [2.3, 4.3] 3.1 [2.4, 4.3] 0.6
 SOFA score 8 [6, 12] 6 [4, 9] 8 [6, 13] 0.008
ICU management
 Mechanical ventilation 91 (54.2) 12 (36.4) 79 (58.5) 0.036
 RRT 59 (35.1) 9 (27.3) 50 (37.0) 0.395
 Steroids 118 (70.2) 17 (51.5) 101 (74.8) 0.016
 Time to etoposide (days) 0 [0, 1]
Outcomes
 HAI 43 (25.6) 2 (6.1) 41 (30.4)
 In-hospital mortality 78 (46.4) 15 (45.5) 63 (46.7)
 Day 90 mortality 83 (49.4) 15 (45.5) 68 (50.4) 0.755

Values are given in N (%) for categorical variables or median [IQR] for continuous variables. Fisher’s exact test for categorical variables, and Kruskal–Wallis test for quantitative variables

SOFA Sequential Organ Failure Assessment, RRT Renal Replacement Therapy, ICU intensive care unit, HLH hemophagocytic lymphohistiocytosis, HIV Human Immunodeficiency Virus, HAI healthcare acquired infection